KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.300
+0.150 (3.61%)
At close: Aug 13, 2025, 4:00 PM
4.380
+0.080 (1.86%)
After-hours: Aug 13, 2025, 4:32 PM EDT
KORU Medical Systems Revenue
KORU Medical Systems had revenue of $10.19M in the quarter ending June 30, 2025, with 20.93% growth. This brings the company's revenue in the last twelve months to $36.85M, up 19.57% year-over-year. In the year 2024, KORU Medical Systems had annual revenue of $33.65M with 17.98% growth.
Revenue (ttm)
$36.85M
Revenue Growth
+19.57%
P/S Ratio
5.18
Revenue / Employee
$460,606
Employees
80
Market Cap
198.81M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 33.65M | 5.13M | 17.98% |
Dec 31, 2023 | 28.52M | 621.63K | 2.23% |
Dec 31, 2022 | 27.90M | 4.41M | 18.76% |
Dec 31, 2021 | 23.49M | -686.27K | -2.84% |
Dec 31, 2020 | 24.18M | 1.01M | 4.38% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Feb 28, 2017 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
KRMD News
- 6 days ago - KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance - Business Wire
- 12 days ago - KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 14 days ago - KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 4 weeks ago - KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire
- 5 weeks ago - KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer - Business Wire
- 2 months ago - KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes - Business Wire
- 3 months ago - KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript - Seeking Alpha